TickerFacts.

Company research / RNXT

RenovoRx, Inc. (RNXT)

Build a valuation ↗↓ Download CSV

CIK 0001574094 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, RenovoRx, Inc. reported revenue of $1.12M. Over the twelve months to 2026-06-30, revenue was $1.98M.

Key ratios (year ended 2025-12-31)

70.9%
Gross margin
n/m
Operating margin
-994.5%
Net margin
-206.0%
Return on year-end equity
n/m
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$1.98M$1.12M$43.0Kn/an/an/an/a
Cost of Revenue$308.0K$327.0K$0n/an/an/an/a
Gross Profit$1.67M$796.0K$43.0Kn/an/an/an/a
R&D Expense$5.63M$6.27M$6.03M$5.67M$4.30M$3.04M$2.39M
Operating Income-$13.54M-$12.51M-$10.97M-$11.40M-$9.95M-$5.67M-$3.20M
Depreciation & Amortizationn/a$2.00M$0n/an/an/an/a
EBITDAn/a-$10.51M-$10.97Mn/an/an/an/a
Net Income-$12.29M-$11.17M-$8.81M-$10.23M-$9.89M-$6.32M-$3.80M
EPS (Diluted)n/a-$0.32-$0.40-$0.99-$1.09n/an/a
Total Assets$11.47M$8.10M$8.12M$1.47M$7.26M$16.29M$1.91M
Total Liabilities$2.49M$2.67M$3.64M$4.47M$1.10M$938.0K$4.12M
Shareholders' Equity$8.98M$5.42M$4.48M-$3.00M$6.16M$15.35M-$14.66M
Cash & Equivalents$9.48M$7.02M$7.15M$1.17M$4.39M$15.19M$1.79M
Operating Cash Flow-$11.87M-$10.97M-$9.12M-$10.26M-$8.81M-$5.92M-$3.53M
Capital Expenditures$71.0K$2.0K$12.0Kn/an/an/an/a
Free Cash Flow-$11.94M-$10.97M-$9.14Mn/an/an/an/a
Shares Outstanding45.12M36.61M24.03M10.69M9.10M8.93M2.23M
Weighted Average Diluted Sharesn/a35.33M22.27M10.29M9.05Mn/an/a
EPS (Basic)n/a-$0.32-$0.40-$0.99-$1.09-$1.21n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView